Advertisement
Advertisement
U.S. markets close in 23 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2200+0.0100 (+0.83%)
As of 03:37PM EDT. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
1/31/2019
Total Revenue
2,045
1,809
860
56,413
Cost of Revenue
-
-
-
24.9197
Gross Profit
-
-
-
56,388
Operating Expense
82,417
87,984
53,194
47,262
Operating Income
-80,372
-86,175
-52,334
9,126
Net Non Operating Interest Income Expense
-844
-281
-251
3,101
Other Income Expense
-3,639
-2,135
-325
-5,628
Pretax Income
-84,866
-88,602
-52,910
6,598
Tax Provision
-
0
-213
-3,274
Net Income Common Stockholders
-84,866
-88,602
-52,697
9,872
Diluted NI Available to Com Stockholders
-84,866
-88,602
-52,697
9,872
Basic EPS
-
-0.96
-0.76
0.12
Diluted EPS
-
-0.96
-0.76
0.12
Basic Average Shares
-
92,294
69,338
85,702
Diluted Average Shares
-
92,294
69,338
86,144
Total Operating Income as Reported
-80,383
-86,186
-53,193
3,498
Total Expenses
82,417
87,984
53,194
47,287
Net Income from Continuing & Discontinued Operation
-84,866
-88,602
-52,697
9,872
Normalized Income
-81,100
-86,467
-51,894
13,980
Interest Income
-
0
4
5.2462
Interest Expense
844
281
255
556.102
Net Interest Income
-844
-281
-251
3,101
EBIT
-84,022
-88,321
-52,655
7,155
EBITDA
-81,513
-
-
-
Reconciled Cost of Revenue
-
-
-
24.9197
Reconciled Depreciation
2,509
2,455
2,003
1,493
Net Income from Continuing Operation Net Minority Interest
-84,866
-88,602
-52,697
9,872
Total Unusual Items Excluding Goodwill
-3,766
-2,135
-805
-5,628
Total Unusual Items
-3,766
-2,135
-805
-5,628
Normalized EBITDA
-77,747
-83,731
-49,847
14,275
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
-2.415
-1,520
Advertisement
Advertisement